Work

A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian cancer

Year: 2020

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2019.12.043

Authors: Bradley J. Monk, Thomas J. Herzog, George Wang, Spyros Triantos, Scott Maul, Roland Knoblauch, Tracy McGowan, Waleed S.W. Shalaby, Robert L. Coleman

Institutions: Creighton University, University of Arizona, The US Oncology Network, University of Cincinnati, Janssen Scientific Affairs (United States), The University of Texas MD Anderson Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Janssen Research and Development

OpenAlex ID: W3000036033

FWCI: 5.776

Cites: 27

Cited by: 44

Related to: 10